Polygenic Risk Scores in Child and Adolescent Psychiatry Survey
Polygenic Risk Scores in Child and Adolescent Psychiatry Survey
批准号:
9927929
负责人:
Gabriel Lazaro-Munoz
金额:
$15.96万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2020-06-30
关键词:
AddressAdolescenceAdolescentAdolescent PsychiatryAge of OnsetAttention deficit hyperactivity disorderAttitudeBenefits and RisksBipolar DisorderChildChild PsychiatryChild RearingChildhoodClinicalDelphi TechniqueDiseaseEarly InterventionEthicsFosteringGeneral PopulationGenomicsGoalsGuidelinesHealthcareIndividualKnowledgeMental DepressionMental HealthMental disordersMorbidity - disease rateOnset of illnessOutcomeParentsPoliciesPreventionPsychiatristResearchResearch PersonnelRiskSchizophreniaServicesSurveysSymptomsTestingautism spectrum disorderclinical careemerging adultexpectationhigh riskimprovedpreventpsychogeneticssocialsocial stigmasuicidal risktool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (Supplement)
Psychiatric genetics researchers have recently identified numerous genomic loci associated with
schizophrenia, depression, autism spectrum disorder, bipolar disorder, attention deficit hyperactivity disorder,
and other disorders. The identification of these genomic loci makes it possible to generate polygenic
risk scores (PRS) to stratify an individual’s risk for different psychiatric disorders compared to the
general population. The usual age of onset for most psychiatric disorders is during childhood, late
adolescence, and early adulthood. As many as 20% of children and adolescents in the U.S. have a
diagnosable psychiatric disorder. Numerous studies suggest that early intervention improves clinical outcomes,
however, the average duration of untreated symptoms and disorders is generally in the order of years. Thus,
there is great need for tools such as PRS to help improve the identification of children and adolescents
at higher risk for psychiatric disorders in order to take steps to potentially prevent or delay the onset
of disease, minimize morbidity and risk for suicide, or provide early intervention.
The promise of reliable PRS in mental health care and prevention is considerable, but there are critical
potential ethical and policy challenges. For example: which children and adolescents, if any, should be
tested; when, if at all, should children and adolescents be tested; where should they be tested; should PRS
testing require a clinician’s order or could it be done through direct-to-consumer services; who should have
access to children and adolescents’ psychiatric PRS results; how should these results be used; what kind of
impact would PRS results have on children and adolescents who are at increased risk; how may high PRS
impact parents/guardians’ expectations and parenting practices; would PRS exacerbate or decrease mental
health stigma and self-stigma for those identified to be at higher risk?
The long-term goal of this research is to develop ethically-justified and empirically-informed guidelines and
tools to address the ethical and policy challenges raised by the use of psychiatric PRS with children and
adolescents. The objective of this supplement, which is the first step in pursuit of this goal, is to identify child
and adolescent psychiatrists’ knowledge, practices, attitudes, expectations, and perceived benefits and risks
about the use of psychiatric PRS. To achieve this objective, we will first use the Delphi technique with expert
child and adolescent psychiatrists to develop the “PRS in Child and Adolescent Psychiatry Survey.” Then, we
will administer the survey to child and adolescent psychiatrists and examine correlates of outcomes. Next
steps include developing an R01 application to more comprehensively examine ethical principles and develop
ethically-justified guidelines to promote the responsible use of psychiatric PRS with children and adolescents.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/s41431-020-00738-0
发表时间:
2021-03
期刊:
European journal of human genetics : EJHG
影响因子:
--
作者:
[Lázaro-Muñoz G, Torgerson L, Smith HS, Pereira S]
通讯作者:
Pereira S
Psychiatric genetics researchers' views on offering return of results to individual participants.
精神病遗传学研究人员对向个人参与者提供结果回报的看法。
DOI:
10.1002/ajmg.b.32682
发表时间:
2019-12
期刊:
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
影响因子:
--
作者:
[Kostick KM, Brannan C, Pereira S, Lázaro-Muñoz G]
通讯作者:
Lázaro-Muñoz G
DOI:
10.1038/s41436-020-00986-x
发表时间:
2021-03
期刊:
Genetics in medicine : official journal of the American College of Medical Genetics
影响因子:
--
作者:
[Lázaro-Muñoz G, Torgerson L, Pereira S]
通讯作者:
Pereira S
DOI:
10.1038/s41436-020-01019-3
发表时间:
2021-03
期刊:
Genetics in medicine : official journal of the American College of Medical Genetics
影响因子:
--
作者:
[Lázaro-Muñoz G, Pereira S, Carmi S, Lencz T]
通讯作者:
Lencz T
Could Genetic Enhancement Really Lead to Obsolescence?
基因增强真的会导致衰老吗?
DOI:
10.1080/15265161.2019.1618962
发表时间:
2019
期刊:
The American journal of bioethics : AJOB
影响因子:
--
作者:
[Zuk,Peter, Kostick,KristinM, Lázaro-Muñoz,Gabriel]
通讯作者:
Lázaro-Muñoz,Gabriel
共 7 条
Polygenic Risk Scores in Child and Adolescent Psychiatry: Ethical, Clinical, and Legal Implications
-
批准号:10696946
-
项目类别:
-
资助金额:$61.67万
-
财政年份:2021
-
负责人:Gabriel Lazaro-Munoz
-
依托单位:
Polygenic Risk Scores in Child and Adolescent Psychiatry: Ethical, Clinical, and Legal Implications
-
批准号:10483181
-
项目类别:
-
资助金额:$62.22万
-
财政年份:2021
-
负责人:Gabriel Lazaro-Munoz
-
依托单位:
Polygenic Risk Scores in Child and Adolescent Psychiatry: Ethical, Clinical, and Legal Implications
-
批准号:10355758
-
项目类别:
-
资助金额:$65.54万
-
财政年份:2021
-
负责人:Gabriel Lazaro-Munoz
-
依托单位:
Ethical Legal and Social Implications of Translational Psychiatric Genomics Research
-
批准号:9116922
-
项目类别:
-
资助金额:$9.11万
-
财政年份:2015
-
负责人:Gabriel Lazaro-Munoz
-
依托单位:
Ethical Legal and Social Implications of Translational Psychiatric Genomics Research
-
批准号:8957341
-
项目类别:
-
资助金额:$8.51万
-
财政年份:2015
-
负责人:Gabriel Lazaro-Munoz
-
依托单位:
海外基金